Gavi signs agreement with Novavax to secure doses on behalf of COVAX Facility

The signed advance purchase agreement (APA) is for a commitment to purchase 350 million doses of the Novavax vaccine candidate. Deliveries will commence in Q3 2021, upon regulatory approval.